Colonial River Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Sell
5,439
-791
-13% -$170K 0.39% 59
2026
Q1
$1.36M Sell
6,230
-149
-2% -$33.1K 0.49% 45
2025
Q4
$1.46M Buy
6,379
+209
+3% +$47.6K 0.52% 42
2025
Q3
$1.43M Sell
6,170
-151
-2% -$30.7K 0.53% 44
2025
Q2
$1.23M Buy
6,321
+1,058
+20% +$197K 0.53% 41
2025
Q1
$1.1M Sell
5,263
-2,278
-30% -$443K 0.61% 38
2024
Q4
$1.34M Sell
7,541
-557
-7% -$102K 0.65% 47
2024
Q3
$1.6M Sell
8,098
-698
-8% -$130K 0.79% 38
2024
Q2
$1.51M Buy
8,796
+156
+2% +$25.8K 0.81% 34
2024
Q1
$1.57M Buy
8,640
+446
+5% +$76.9K 0.89% 31
2023
Q4
$1.27M Sell
8,194
-2,100
-20% -$306K 0.75% 40
2023
Q3
$1.53M Buy
10,294
+5,810
+130% +$853K 1% 31
2023
Q2
$604K Sell
4,484
-24
-0.5% -$3.52K 0.4% 74
2023
Q1
$718K Buy
4,508
+194
+4% +$29.7K 0.42% 69
2022
Q4
$697K Buy
4,314
+138
+3% +$21.2K 0.45% 64
2022
Q3
$560K Sell
4,176
-381
-8% -$54.7K 0.39% 77
2022
Q2
$698K Buy
4,557
+9
+0.2% +$1.38K 0.46% 64
2022
Q1
$737K Sell
4,548
-844
-16% -$123K 0.43% 71
2021
Q4
$730K Buy
+5,392
New +$637K 0.39% 71
2021
Q3
Sell
-3,450
Closed -$389K 71
2021
Q2
$389K Buy
3,450
+80
+2% +$9.01K 0.28% 94
2021
Q1
$365K Sell
3,370
-139
-4% -$14.9K 0.29% 91
2020
Q4
$369 Buy
+3,509
New +$337K 0.17% 85

Other funds holding ABBV

Colonial River Investments's ABBV Position: Q2 2026 in Review

Colonial River Investments reduced its AbbVie (ABBV) stake by 13% in Q2 2026, selling an estimated $170K and leaving 5,439 shares worth $1.37M. The position accounts for 0.39% of the portfolio, ranked #59.

Colonial River Investments first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.6M in Q3 2024. 2,345 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Colonial River Investments held 5,439 shares of AbbVie worth $1.37M as of Q2 2026.
  • Colonial River Investments sold 791 AbbVie shares in Q2 2026, an estimated $170K.
  • AbbVie made up 0.39% of Colonial River Investments's portfolio in Q2 2026, its #59 holding.
  • Colonial River Investments first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • Colonial River Investments's AbbVie position peaked at $1.6M in Q3 2024.
  • 2,345 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Colonial River Investments's 13F filing for Q2 2026, filed 24 Jul 2026.